- NSE
- WINDLAS
- BSE
- 543329
- ISIN
- INE0H5O01029
WINDLAS BIOTECH
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹974.25
−₹20.15 (−2.03%)
NSE close ·
WINDLAS BIOTECH closed at ₹974.25 on 9 Nov 2026, down 2.03% on the day, and is up 12.00% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹705.75 to ₹1,154.75.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹2,010 Cr
- Industry P/E
- 35.5
- Dividend yield
- 0.65%
Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹253 Cr | ₹17.65 Cr | — | ₹8.32 |
| Mar 2026 | ₹243 Cr | ₹16.02 Cr | — | ₹7.50 |
Armor risk check
WINDLAS BIOTECH moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is WINDLAS BIOTECH's share price today?
WINDLAS BIOTECH (NSE: WINDLAS) closed at ₹974.25 on 9 Nov 2026, down 2.03% from the previous close of ₹994.40. It traded between ₹970.65 and ₹1,012.35 that day.
What are WINDLAS BIOTECH's 52-week high and low?
Over the last 52 weeks WINDLAS BIOTECH traded between ₹697.40 and ₹1,181.90, adjusted for splits and bonuses.
What are WINDLAS BIOTECH's NSE symbol, BSE code and ISIN?
WINDLAS BIOTECH has NSE symbol WINDLAS, BSE code 543329, ISIN INE0H5O01029.
How has WINDLAS BIOTECH performed over 1, 3 and 5 years?
WINDLAS BIOTECH's share price return: 1Y +12.00%, 3Y +36.96% a year, 5Y +26.01% a year. Dividends are not included.
Does WINDLAS BIOTECH pay a dividend?
Yes. WINDLAS BIOTECH's latest dividend went ex on 16 Jul 2026: Final · ₹6.30 per share. Dividends over the past year come to a yield of 0.65% at the latest close.
What is WINDLAS BIOTECH's market cap?
WINDLAS BIOTECH's market cap is ₹2,010 Cr at the close on 9 Nov 2026.
Which sector is WINDLAS BIOTECH in?
WINDLAS BIOTECH is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how WINDLAS BIOTECH fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app